Specific gut microbes boost cancer immunotherapy in obese patients

New research published in *Nature* shows that a specific combination of gut bacteria can make immunotherapy more effective for cancer patients with obesity. This finding, from a study led by Dr. Romina Goldszmid at the National Cancer Institute, suggests that personalized microbiome interventions could be a future pathway for better treatment outcomes.